MM411 Collaboration with Russo’s CreDO Science Will Deliver Accurate, Evidence-based Cannabis and Endocannabinoid system (ECS) Education
Initial, Foundational Offering Now Available Through MM411 with Expanded Courses Planned for September
Class Tailored to Medical Professionals, Patients, Caregivers, Advocates, and Industry Workers
[May 2, 2024] – Medical Marijuana 411 (MM411), the leading global provider of digital cannabis education, today announced a groundbreaking collaboration with CReDO Science, led by Dr. Ethan Russo, a board-certified neurologist and the world’s preeminent medical cannabis clinician and researcher, to deliver accurate, evidence-based cannabis and endocannabinoid system education. An initial foundational class developed by Dr. Russo, MM411 President Christine DeVol, and Nishi Whiteley, MS, Chief Operating Officer of CReDO Science, is now available in English, Spanish, and Japanese through MM411 and features 8 webinar modules totaling 11 hours, with an expanded, follow-up class planned for September.
“We are thrilled to join forces with CReDO Science to offer this unparalleled digital cannabis education platform,” said President DeVol. “By combining our expertise in digital education with Dr. Russo’s extensive research and clinical expertise, we are poised to greatly improve the quality of cannabis education available to all as we create a legacy of his decades of groundbreaking work.”
“Cannabis has immense therapeutic potential, but misinformation and stigma often cloud its true benefits and medical use,” said Dr. Russo. “Through this collaboration with MM411 we hope to empower healthcare professionals, patients, and advocates around the globe with accurate, science-backed knowledge to fully understand the risks and benefits of cannabis use. Together, we can transform the cannabis landscape.”
Through the collaboration, Dr. Russo is distilling decades of peer-reviewed scientific studies along with his 28 years of clinical cannabis experience to ensure students receive the most accurate and up-to-date information on cannabis and its potential medical applications in a format that is comprehensible to a wide-reaching audience of medical professionals, patients, caregivers, advocates, and industry workers. As part of the experience, Dr. Russo incorporates detailed citations throughout course materials, allowing students to understand from where his lessons are based and granting them further access to the tools they will need to dive deeper.
The initial course offering aims to demystify the mechanisms by which cannabis components interact with the human body. It will make understandable the science behind cannabis and the human endocannabinoid system. This will empower healthcare professionals to integrate cannabis in their practices, patients looking to understand the science behind their treatment, and industry professionals to better serve their customers. By helping learners to make informed decisions about its use, the program will contribute to the safety and efficacy of cannabis consumption worldwide.
For more information about the collaboration between MM411 and CReDO Science and to enroll in the digital cannabis education courses, visit here. Join us on this transformative journey toward a better-informed cannabis community.
Cannabis use is growing worldwide evidenced by The United Nations World Drug Report of 2023 which estimates 219 million people worldwide use cannabis. The US government report 2022 National Survey on Drug Use and Health estimates 59 million people 18 and older used cannabis in the year prior. But cannabis education has fallen behind. According to the journal article, Physicians-in-training are not prepared to prescribe medical marijuana by Evanoff et al, 89.5% of residents and fellows graduating from American medical schools felt they were not at all prepared to prescribe medical marijuana, 35.3% felt not at all prepared to answer questions, and 84.9% reported receiving no education in medical school or residency on medical marijuana. The report further outlined only 9% of medical school curriculums included content on medical cannabis.
About MM411:
MM411 https://medicalmarijuana411.com Founded in 2009, MM411 is the global leader in medical cannabis education. Thousands of medical professionals from 20 different countries have taken MM411 research-based cannabis courses. With cannabis education programs approved by more U.S. states than any other organization, MM411 offers medical cannabis certifications and aligns with government entities to develop certification programs for medical and industry professionals, U.S. state-required certifications for healthcare professionals, and cannabis consultants (budtenders). Certifications are focused on areas such as federal and state marijuana laws, science, endocannabinoid system, approved conditions, safe handling, dispensary customer service, how to use various product methods, and dosing.
About CReDO Science: CReDO Science https://credo-science.com is a private company that offers licensing of its innovations, provides clinical cannabis research consulting and formulation and product development consulting for wellness, medical, adult-use and pharmaceutical products.
###
Media Contact:
Freeman Klopott
Fklopott@marinopr.com
